EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Impact of HMGB1 on cancer development and therapeutic insights focused on CNS malignancy

Sucharita Patra, Pritam Kumar Roy, Ankita Dey, Mahitosh Mandal

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2024

DOI: 10.1016/j.bbcan.2024.189105 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2024. Verfasst von Sucharita Patra und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Biology Lab, School of Medical Science and Technology, Indian Institute of Technology Kharagpur, West Bengal, India. Electronic address: sucha…. Hauptthemen laut MEDLINE: HMGB1 Protein, Tumor Microenvironment, Glioblastoma, Central Nervous System Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 171 Literaturangaben. Gefördert von: Indian Council of Medical Research, Indian Institute of Technology Kharagpur, Department of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The present study explores the complex roles of High Mobility Group Box 1 (HMGB1) in the context of cancer development, emphasizing glioblastoma (GBM) and other central nervous system (CNS) cancers. HMGB1, primarily known for its involvement in inflammation and angiogenesis, emerges as a multifaceted player in the tumorigenesis of GBM. The overexpression of HMGB1 correlates with glioma malignancy, influencing key pathways like RAGE/MEK/ERK and RAGE/Rac1. Additionally, HMGB1 secretion is linked to the maintenance of glioma stem cells (GSCs) and contributes to the tumor microenvironment's (TME) vascular leakiness. Henceforth, our review discusses the bidirectional impact of HMGB1, acting as both a promoter of tumor progression and a mediator of anti-tumor immune responses. Notably, HMGB1 exhibits tumor-suppressive roles by inducing apoptosis, limiting cellular proliferation, and enhancing the sensitivity of GBM to therapeutic interventions. This dualistic nature of HMGB1 calls for a nuanced understanding of its implications in GBM pathogenesis, offering potential avenues for more effective and personalized treatment strategies. The findings underscore the need to explore HMGB1 as a prognostic marker, therapeutic target, and a promising tool for stimulating anti-tumor immunity in GBM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HMGB1 ProteinTumor MicroenvironmentGlioblastomaCentral Nervous System NeoplasmsHumansAnimalsNeoplastic Stem CellsSignal TransductionCell Proliferation

Stichwörter der Autor:innen

Cancer hallmarksCancer resistanceGlioblastomaHigh mobility group box 1Therapeutics

Substanzen

HMGB1 ProteinHMGB1 protein, human

Autor:innen und Institutionen

  • Cancer Biology Lab, School of Medical Science and Technology, Indian Institute of Technology Kharagpur, West Bengal, India. Electronic address: sucharitapatra19@gmail.com.
  • Cancer Biology Lab, School of Medical Science and Technology, Indian Institute of Technology Kharagpur, West Bengal, India. Electronic address: pritamroy@iitkgp.ac.in.
  • Cancer Biology Lab, School of Medical Science and Technology, Indian Institute of Technology Kharagpur, West Bengal, India. Electronic address: andyred419@gmail.com.
  • Cancer Biology Lab, School of Medical Science and Technology, Indian Institute of Technology Kharagpur, West Bengal, India. Electronic address: mahitosh@smst.iitkgp.ac.in.

Förderung

  • Indian Council of Medical Research
  • Indian Institute of Technology Kharagpur
  • Department of Science and Technology

Zitieren

APA

Patra, S., Roy, P. K., Dey, A., & Mandal, M. (2024). Impact of HMGB1 on cancer development and therapeutic insights focused on CNS malignancy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. https://doi.org/10.1016/j.bbcan.2024.189105

Vancouver

Patra S, Roy PK, Dey A, Mandal M. Impact of HMGB1 on cancer development and therapeutic insights focused on CNS malignancy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2024. doi:10.1016/j.bbcan.2024.189105

BibTeX
@article{Patra2024,
  author = {Patra, Sucharita and Roy, Pritam Kumar and Dey, Ankita and Mandal, Mahitosh},
  title = {Impact of HMGB1 on cancer development and therapeutic insights focused on CNS malignancy},
  journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
  year = {2024},
  doi = {10.1016/j.bbcan.2024.189105}
}
Kostenlos starten →